Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.58 |
| ▸ | MEN1 | O00255 | 2/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.54 |
| ▸ | ANO1 | Q5XXA6 | 1/20 | 0.49 |
| ▸ | HPGD | P15428 | 2/20 | 0.48 |
| ▸ | GAA | P10253 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.47 |
| ▸ | RECQL | P46063 | 1/20 | 0.47 |
| ▸ | KCNK3 | O14649 | 3/20 | 0.47 |
| ▸ | KCNK9 | Q9NPC2 | 3/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.46 |
| ▸ | GRM5 | P41594 | 1/20 | 0.46 |
| ▸ | NPC1 | O15118 | 1/20 | 0.46 |
| ▸ | RAB9A | P51151 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7235988 | 0.86 | KMT2A (0.50) | MAPTMEN1KMT2AHPGDSMN1; SMN2 | |
| SCHEMBL7239176 | 0.85 | MEN1 (0.49) | MAPTMEN1KMT2AANO1HPGD | |
| SCHEMBL7245811 | 0.85 | F2R (0.51) | MAPTMEN1KMT2AHPGDSMN1; SMN2 | |
| SCHEMBL7246916 | 0.85 | MAPT (0.54) | MAPTMEN1KMT2AHPGDSMN1; SMN2 | |
| SCHEMBL7240517 | 0.84 | MEN1 (0.48) | MEN1KMT2AHPGDKCNK3KCNK9 | |
| SCHEMBL7243023 | 0.81 | ALDH1A1 (0.49) | MAPTMEN1KMT2AHPGDSMN1; SMN2 | |
| SCHEMBL7245520 | 0.81 | MAPT (0.58) | MAPTMEN1KMT2AANO1HPGD | |
| SCHEMBL7238246 | 0.80 | ALDH1A1 (0.54) | MEN1KMT2AGAASMN1; SMN2KCNK3 | |
| SCHEMBL7242939 | 0.79 | MGLL (0.60) | MEN1KMT2AHPGDSMN1; SMN2RAB9A | |
| SCHEMBL7240807 | 0.78 | MEN1 (0.44) | MAPTMEN1KMT2AHPGDKCNK3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030083523-A1 | Amide derivatives | MITSUBISHI CHEMICAL CORPORATION (JP) | 2003-05-01 | — | — | US | disclosed |
| US-6444849-B1 | BACTERICIDES | MITSUBISHI CHEMICAL CORPORATION (JP) | 2002-09-03 | — | — | US | disclosed |
| EP-1142868-A1 | AMIDE DERIVATIVES | MITSUBISHI CHEMICAL CORPORATION (JP) | 2001-10-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030083523-A1 | Amide derivatives | H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, CBR3, CBR1 | MAPT 3965/4885MEN1 2901/4885KMT2A 1956/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.